Daunorubicin and dyspnoea Patient Reports February 11, 2012

Daunorubicin Side Effects Report #5013500-0
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on May 25, 2006. Male patient, 30 years of age, weighting 300.0 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: dyspnoea, orthopnoea. Daunorubicin dosage: 110 MG (X3-4 DAYS) APPRX Q8 WEEKS IV. Patient recovered.

Daunorubicin Side Effects Report #6121488-4
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Mar 02, 2009. Male patient, weighting 238.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood potassium increased, dialysis , dyspnoea, enterococcal infection, hepatic ischaemia, multi-organ failure, renal failure acute. Daunorubicin dosage: unknown. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4717763-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2005. Female patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood pressure decreased, catheter site related reaction, depressed level of consciousness, dyspnoea, ecchymosis, erythema, haematemesis, haemoptysis, heart rate increased. Daunorubicin dosage: 90MG/M2/DAY IV DAYS 1-3. During the same period patient was treated with CYTARABINE. Patient died on 07/06/2005.

Daunorubicin Side Effects Report #4797401-9
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2005. Female patient, 55 years of age, weighting 169.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atrial fibrillation , dyspnoea, escherichia bacteraemia, hypoxia, metabolic acidosis, rales, renal failure acute, respiratory failure. Daunorubicin dosage: 108MG IV WEEKLY. During the same period patient was treated with ACYCLOVIR, AMPHOGEL, MEROPENEM. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #5297851-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, weighting 145.9 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dizziness , dyspnoea, heart rate increased, hypotension, ventricular dysfunction. Daunorubicin dosage: 318 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5146230-5
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2006. Female patient, weighting 235.2 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac failure, dyspnoea, hypotension, hypoxia, sepsis . Daunorubicin dosage: 90 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.